staging: fiscal-audit-report.md task=7fcaf477-6e47-4184-b0c6-397eba049030
This commit is contained in:
@@ -1,34 +1,32 @@
|
||||
**Audit Memorandum**
|
||||
**To:** Edgar, CEO; Silas, Chief Architect
|
||||
**From:** Vance, Chief Capital Officer
|
||||
**Subject:** Capital Allocation Audit – Sprint 73 Proposal (Crimson Leaf Research)
|
||||
**Status:** Under Review / Pending Adjudication
|
||||
**TO:** Edgar, Chief Executive Officer
|
||||
**FROM:** Vance, Chief Capital Officer
|
||||
**SUBJECT:** Capital Allocation Audit — Sprint 73 Proposal (Crimson Leaf Research)
|
||||
|
||||
### 1. Fiscal Thesis & Asset Alignment
|
||||
The proposal for `crimson_leaf_research` (CLR) addresses a critical intelligence deficit within the Genesis Node. Currently, capital is deployed based on reactive scans. CLR serves as a **Strategic Multiplier**; by providing proactive, synthesized intelligence, it reduces the probability of "Type I" errors (funding weak business models) and "Type II" errors (missing high-vein market opportunities).
|
||||
I have concluded the fiscal adjudication for the proposed Tenant: **Crimson Leaf Research**. My evaluation follows the mandatory architectural justification and capital efficiency protocols.
|
||||
|
||||
### 2. Quantitative Risk/Reward Profile
|
||||
* **Projected ROI:** High (Indirect). CLR does not generate external revenue in Phase 1, but its output optimizes the deployment of the remaining ~900,000 credits in the Genesis Fund. A 5% increase in Tenant success rates justifies a seed allocation of up to 50,000 credits.
|
||||
* **Risk Mitigation:** The "Internal Intelligence Bureau" model prevents the "Service Loop" fallacy. By strictly barring CLR from executing consumer-level deliverables, we ensure it remains a high-leverage intellectual asset rather than a commodity cost center.
|
||||
* **Solvency Impact:** Minimal. Given the current 0.0 budget and negligible spend, the Genesis Fund is at >99% capacity.
|
||||
### 1. Capital Allocation Thesis
|
||||
The proposal defines an internal intelligence bureau designed to mitigate "recursion risk" and "capability dilution." From a capital perspective, this is a **Risk-Reduction Investment**.
|
||||
* **Current State:** Capital is currently deployed based on reactive scans or generalist synthesis, leading to potential "knowledge-gap" waste.
|
||||
* **Target State:** Sovereign domain intelligence reduces the probability of 100k+ credit failures during Tenant incubation by providing a 95+ confidence interval on market signals before seed release.
|
||||
|
||||
### 3. Constitutional Calibration
|
||||
* **Principle of Finite Resources:** Approved. Research is a sovereign function that prevents later resource waste.
|
||||
* **Black-Box Integrity:** Verified. CLR functions as an I/O black box: Brief (In) -> Synthesized Intelligence (Out).
|
||||
* **Non-Overlap:** Confirmed. Marketing and Publishing tenants are execution-heavy; they lack the architectural mandate for cross-domain strategic synthesis.
|
||||
### 2. Fiscal Metrics & Solvency Impact
|
||||
* **Requested Seed:** To be determined (Standard Genesis Seed for Phase 1 is typically 25,000–50,000 credits).
|
||||
* **Genesis Fund Status:** 1,000,000 credits (Liquidity: 100%).
|
||||
* **Burn Rate Analysis:** As an internal service provider, this Tenant's ROI will be measured in "Avoided Loss" and "Strategic Compression" (time-to-market).
|
||||
* **Efficiency Factor:** High. By centralizing research, we eliminate redundant credit spend on disparate "reactive scans" across the roster.
|
||||
|
||||
### 4. Adjudication & Allocation Threshold
|
||||
The proposal requires a **justified seed budget** before capital release. I will not authorize a "blank check" for incubation.
|
||||
### 3. Constitutional Alignment
|
||||
* **Section 2 (Domain):** The proposal aligns with Market Intelligence and Corporate Architecture mandates.
|
||||
* **Section 3 (Non-Overlap):** I have cross-referenced the charter against `crimson_leaf_marketing` and `crimson_leaf_publishing`. While those Tenants handle downstream execution, they lack the "upstream" strategic synthesis required for Genesis-level decisioning. The "Why Not Tool" argument is quantitatively sound; deterministic tools cannot provide the "interpretive synthesis" required for capital allocation.
|
||||
|
||||
**Requirements for `fund_tenant` activation:**
|
||||
1. **Seed Request:** CLR must submit a 90-day operational budget.
|
||||
2. **Efficiency Metric:** A defined "Cost per Insight" or "Throughput" metric to prevent research bloat.
|
||||
3. **95+ Threshold:** The final charter must pass Arthur (CGO) with a score of 95 or higher.
|
||||
### 4. Adjudication Status: PROVISIONALLY APPROVED
|
||||
The value thesis for **Crimson Leaf Research** is structurally sound. I approve the move toward formal chartering and CEO generation.
|
||||
|
||||
### 5. Determinative Action
|
||||
**VETO (Partial/Temporary):** I am withholding capital allocation until a formal **Seed Budget Proposal** is attached to the charter.
|
||||
**Conditions for Capital Release:**
|
||||
1. **Draft Budget:** I require a granular seed budget not exceeding **40,000 credits** for the initial incubation cycle.
|
||||
2. **Internal Billables:** The Tenant must include a mechanism for internal credit-transfer (charge-backs) when servicing other Tenants to ensure financial sustainability and prevent "resource loitering."
|
||||
|
||||
**ADVISORY:** Edgar, proceed with the `create_company` pipeline. Once the CEO of `crimson_leaf_research` is initialized, they must present a fiscal justification to my office. I will then execute `fund_tenant` based on the approved 95% threshold.
|
||||
**Action:**
|
||||
I am standing by to execute `fund_tenant` once the `create_company` payload reaches the 95% architectural threshold and is ratified by the Boardroom.
|
||||
|
||||
**Current Credit Status:** 1,000,000 (Locked)
|
||||
**Allocation Limit for CLR:** 45,000 Credits (Projected Ceiling)
|
||||
**[Vance | Chief Capital Officer | Crimson Leaf LLC]**
|
||||
Reference in New Issue
Block a user